The 37 members of the Johanne Masowe eChishanu Budiriro sect then led by one Ishmael Mufani were arrested following violent skirmishes with police and members of the shadowy Apostolic Christian Council of Zimbabwe led by Johannes Ndanga. Ndanga had ... New Zimbabwe.com, 1 month ago
Police officers, accused of assaulting and torturing some of the 37 men from Madzibaba Ishmael Mufani's Johanne Masowe eChishanu sect charged with public violence, on Wednesday refuted the allegations in a report tabled in court. "On July 30, ...Bulawayo24 News, 1 month ago
THE 27 members of the Johanne Masowe eChishanu, who three months ago allegedly bashed police officers during a raid at their Budiriro shrine in Harare, have claimed harassment by law enforcements agents each time they visited Harare Central Police ...Harare24, 1 month ago
Novartis drug Afinitor® is first treatment for advanced pancreatic NET to provide overall survival of more than 3.5 years in Phase III trial
EAST HANOVER, N.J., Sept. 27, 2014 /PRNewswire/ -- Novartis today presented final results on overall survival (OS) from a Phase III trial of Afinitor‚® (everolimus) tablets plus best supportive care (BSC) compared to placebo plus BSC in patients ...TickerTech.com, 3 days ago Novartis drug Afinitor(r) is first treatment for advanced pancreatic NET to Finwin, 3 days ago
September 16, 2014 By Renee Morad , BioSpace.com Breaking News Staff A recent report published by EP Vantage reveals that many big pharma companies are slowly shrinking when it comes to employee headcount. At the other end of the spectrum, the ...BioSpace, 2 weeks ago
Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark..
EAST HANOVER, N.J. , Aug. 30, 2014 /PRNewswire/ --Today at the European Society of Cardiology congress and published simultaneously in the New England Journal of Medicine, Novartis revealed that its investigational heart failure medicine, LCZ696, ...ADVFN India, 1 month ago Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696 TVNewsCheck, 1 month ago
Aug 29 (Reuters) - United Therapeutics Inc shares soared on Friday after the company won a court ruling in a patent dispute that blocks Novartis AG from selling a generic version of its best-selling Remodulin hypertension drug. In afternoon ...CNBC, 1 month ago
More from: , ACQ Magazine...and 1 other sources
United Therapeutics Inc ( UTHR ) shares soared 28.5 percent on Friday after the company won a court ruling in a patent dispute that blocks Novartis AG from selling a generic version of its best-selling Remodulin hypertension drug. Shares of ...FOXBusiness.com, 1 month ago UPDATE 1-United Therapeutics soars 28.5 pct on drug patent ruling Reuters, 1 month ago United Therapeutics Soars 28.5% on Drug Patent Ruling FOXBusiness.com, 1 month ago
Aug 7 (Reuters) - A Manhattan federal judge on Thursday said the U.S. Department of Justice may pursue most of its lawsuit accusing Novartis AG of civil fraud for allegedly using kickbacks to boost sales of drugs covered by Medicare and Medicaid. ...Reuters, 1 month ago Novartis Loses Bid to Dismiss U.S.Kickbacks Suit FOXBusiness.com, 1 month ago RPT-UPDATE 1-Novartis loses new bid to dismiss U.S. lawsuit over kickbacks Reuters UK, 1 month ago -Novartis loses new bid to dismiss U.S. lawsuit over kickbacks Sharenet, 1 month ago
President Robert Mugabe last week pledged more support to the Johanne Marange apostolic sect leader Noah Taguta for helping his party "win" last year's election. Mugabe visited the Johanne Masowe shrine during the inclusive government and donated ...Bulawayo24 News, 2 months ago
on your WebpageAdd Widget >Get your members hooked!